Berenberg keeps Buy rating and GBp 2,200 target for GSK stock

Published on 10/07/2026 at 10:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

GSK stock costs EUR 20.82 on October 7, 2026 versus EUR 20.79. Market value was GBP 70.8 billion on October 6, 2026 in London.

Moderne Pharma-Produktionsanlage mit Glasfassade und Laboren bei Dämmerlicht — GSK plc (ISIN GB0009252882) betreibt moderne Pharmaanlagen mit Laboren und Produktionshallen in der Abenddämmerung, Illustration mit AI erstellt.

GSK (ISIN GB00BN7SWP63) was trading at EUR 20.82 at Lang & Schwarz on October 7, 2026 at 10:08 a.m. CEST, plus 0.14 percent versus the prior close of EUR 20.79. According to finanzen.ch on October 7, 2026, Berenberg kept its Buy rating and GBp 2,200 price target for GSK.

Berenberg highlights oncology catalyst

Berenberg analyst Luisa Hector pointed to GSK's Ris-Rez lung cancer medicine ahead of the European Society for Medical Oncology congress starting October 23, 2026, according to finanzen.ch.

The target is denominated in GBp, while the reference quote here is in EUR, so the two prices are kept as separate market references. That distinction matters because a target comparison requires the same currency and venue.

Regulatory filing adds share count

A GSK filing dated October 6, 2026 reported that 19,352 ordinary shares were admitted to trading under the Share Save Plan 2022. The filing said total securities admitted following the transaction reached 4,316,311,662, according to StockTitan.

The filing also identified the London Stock Exchange Main Market and the ISIN as GB00BN7SWP63. The new shares therefore relate to the same ordinary security covered by the London listing.

Stock valuation and next date

GSK's London quotation was listed at GBp 1,760.50 in the finance data snapshot on October 7, 2026, down GBp 5.00 from the prior close of GBp 1,765.50. The separate Lang & Schwarz quote provides the euro reference for German-market investors.

Investing.com lists GSK's next earnings report for October 28, 2026 and shows a market value of GBP 70.8 billion in its October 6, 2026 market overview, while the latest release listed there was dated July 28, 2026. The calendar date gives the next defined reporting checkpoint for the stock.

GSK stock stays near its market reference

At Lang & Schwarz, GSK was trading at EUR 20.82 on October 7, 2026 at 10:08 a.m. CEST, plus 0.14 percent versus the Lang & Schwarz prior close of EUR 20.79. The modest daily move places the analyst target and the October 28 reporting date ahead of the market's next clearly dated information points.

The further course of trading is shown by the continuously updated real-time quote of GSK stock.